Skip to main content

X4 Pharmaceuticals, Inc

XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501697

In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding X4 Pharmaceuticals, Inc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of XFOR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders5459+5
Shares60.6M61.5M+841.1K (+1.4%)
Value$60.2M$53.6M−$6.58M (−10.9%)

New holders (13)

Institutions that held X4 Pharmaceuticals, Inc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to XFOR in Q1 2023
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC4,545,454$3.95M0.12%
Scoggin Management LP484,796$567.0K0.83%
Simplify Asset Management Inc.400,000$348.0K0.06%
Susquehanna International Group, LLP282,547$245.8K0.00%
Virtu Financial LLC113,489$99.0K0.01%
UBS Group AG100,000$87.0K0.00%
XTX Topco Ltd96,649$84.1K0.02%
Landscape Capital Management, L.L.C.42,252$36.8K0.01%
CIBC Private Wealth Group, LLC41,500$36.1K0.00%
Jane Street Group, LLC21,568$18.8K0.00%
Mission Wealth Management, LP15,000$13.1K0.00%
Total Clarity Wealth Management, Inc.11,000$9.57K0.01%
FMR LLC3$30.00%

Sold out (8)

Institutions that held X4 Pharmaceuticals, Inc at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of XFOR in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
CVI Holdings, LLC2,381,923$2.37M
Sio Capital Management, LLC1,825,963$1.81M
BVF Inc1,347,650$1.34M
PEAK6 Investments LLC20,200$20.1K
Cutler Group LP12,200$12.0K
High Net Worth Advisory Group LLC1,100$1.09K
Bank of America Corp272$270
Rockefeller Capital Management L.P.1,000$0